SFX by Ex Libris Inc.

Title:	Genetics. Simple genetics for a complex disease
Source:	Science [0036-8075] Cohen, J C yr:2013

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Rader, Daniel J J. "Monogenic hypercholesterolemia: new insights in pathogenesis and treatment." The journal of clinical investigation 111.12 (2003): 1795-803.
description	2.	Canuel, M. "Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Can Mediate Degradation of the Low Density Lipoprotein Receptor-Related Protein 1 (LRP-1)." PLoS ONE 8.5 (2013).
description	3.	Parker, Rex A A. "Bile Acid and Sterol Metabolism with Combined HMGCoA Reductase and PCSK9 Suppression." Journal of lipid research 54.9 (2013): 2400-2409.
description	4.	Barrett, Helena C. "How next-generation sequencing is transforming complex disease genetics." Trends in genetics 29.1 (2012): 23-30.
description	5.	Glocker, Michael O O. "Rheumatoid arthritis, a complex multifactorial disease: on the way toward individualized medicine." Medicinal research reviews 26.1 (2005): 63-87.
description	6.	Portin, P. "Evolution of man in the light of molecular genetics: a review. Part I. Our evolutionary history and genomics." Hereditas 144.3 (2007): 80-95.
description	7.	Rohrl, C. "HDL endocytosis and resecretion." Biochimica and biophysica acta. Molecular and cell biology of lipids 1831.11 (2013): 1626-1633.
description	8.	Choi, S. "Decreased APOE-containing HDL subfractions and cholesterol efflux capacity of serum in mice lacking Pcsk9." Lipids in Health and Disease 12.1 (2013): 112-112.
description	9.	Cariou, B. "PCSK9: a new target for hypercholesterolemia." Fundamental & clinical pharmacology 2013. 16-16.
description	10.	DeVay, Rachel M. "Characterization of proprotein convertase subtilisin/kexin type 9 (PCSK9) trafficking reveals a novel lysosomal targeting mechanism via amyloid precursor-like protein 2 (APLP2)." Journal of biological chemistry 288.15 (2013): 10805-18.
description	11.	Vandrovcova, J. "The use of next-generation sequencing in clinical diagnosis of familial hypercholesterolemia." Genetics in medicine 15.12 (2013): 948-57.
description	12.	Ahmed, W. "The genetic spectrum of Familial Hypercholesterolemia in Pakistan." Clinica chimica acta (2013): 219-25.
description	13.	Nsengimana, J. "Design considerations for genetic linkage and association studies." Methods in molecular biology 850 (2012): 237-262.
description	14.	Blaxter, Mark L. "Genome-wide genetic marker discovery and genotyping using next-generation sequencing." Nature reviews. Genetics 12.7 (2011): 499-510.
description	15.	Day-Williams, Aaron G. "The effect of next-generation sequencing technology on complex trait research." European journal of clinical investigation 41.5 (2010): 561-567.
description	16.	Bagshaw, R. "A proteomic analysis of lysosomal integral membrane proteins reveals the diverse composition of the organelle." Molecular & cellular proteomics 4.2 (2005): 133-143.
description	17.	Ng, Pauline C. "Whole genome sequencing." Methods in molecular biology 628 (2010): 215-26.
description	18.	Krusekopf, S. "St. John's wort and its constituent hyperforin concordantly regulate expression of genes encoding enzymes involved in basic cellular pathways." Pharmacogenetics and genomics 15.11 (2005): 817-29.
description	19.	Avouac, J. "Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review." Annals of the rheumatic diseases 65.7 (2006): 845-851.
description	20.	Nash, David T T. "Use of vascular ultrasound in clinical trials to evaluate new cardiovascular therapies." Journal of the National Medical Association 100.2 (2008): 222-9.